Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 132
Filter
1.
Eur J Neurosci ; 44(12): 3001-3010, 2016 12.
Article in English | MEDLINE | ID: mdl-27740705

ABSTRACT

Neurogenesis in the dentate gyrus is sensitive to endogenous and exogenous factors that influence hippocampal function. Ongoing neurogenesis and the integration of these new neurons throughout life thus may provide a sensitive indicator of environmental stress. We examined the effects of Aroclor 1254 (A1254), a mixture of polychlorinated biphenyls (PCBs), on the development and function of newly generated dentate granule cells. Early exposure to A1254 has been associated with learning impairment in children, suggesting potential impact on the development of hippocampus and/or cortical circuits. Oral A1254 (from the 6th day of gestation to postnatal day 21) produced the expected increase in PCB levels in brain at postnatal day 21, which persisted at lower levels into adulthood. A1254 did not affect the proliferation or survival of newborn neurons in immature animals nor did it cause overt changes in neuronal morphology. However, A1254 occluded the normal developmental increase in sEPSC frequency in the third post-mitotic week without altering the average sEPSC amplitude. Our results suggest that early exposure to PCBs can disrupt excitatory synaptic function during a period of active synaptogenesis, and thus could contribute to the cognitive effects noted in children exposed to PCBs.


Subject(s)
/toxicity , Excitatory Postsynaptic Potentials/drug effects , Hippocampus/drug effects , Hippocampus/growth & development , Neurons/drug effects , Prenatal Exposure Delayed Effects/physiopathology , Synapses/drug effects , Animals , Cell Proliferation/drug effects , Cell Survival/drug effects , Female , Hippocampus/physiology , Mice , Mice, Inbred C57BL , Neurogenesis/drug effects , Neurons/physiology , Pregnancy , Prenatal Exposure Delayed Effects/chemically induced , Synapses/physiology , Thyroid Hormones/metabolism
2.
Andrology ; 4(4): 706-22, 2016 07.
Article in English | MEDLINE | ID: mdl-27285165

ABSTRACT

The developing brain is remarkably malleable as neural circuits are formed and these circuits are strongly dependent on hormones for their development. For those reasons, the brain is very vulnerable to the effects of endocrine-disrupting chemicals (EDCs) during critical periods of development. This review focuses on three ubiquitous endocrine disruptors that are known to disrupt the thyroid function and are associated with neurobehavioral deficits: polychlorinated biphenyls, polybrominated diphenyl ethers, and bisphenol A. The human and rodent data suggesting effects of those EDCs on memory, cognition, and social behavior are discussed. Their mechanisms of action go beyond relative hypothyroidism with effects on neurotransmitter release and calcium signaling.


Subject(s)
Cognition/drug effects , Endocrine Disruptors/toxicity , Environmental Exposure/adverse effects , Memory/drug effects , Thyroid Gland/drug effects , Animals , Behavior, Animal/drug effects , Benzhydryl Compounds/toxicity , Halogenated Diphenyl Ethers/toxicity , Humans , Phenols/toxicity , Polychlorinated Biphenyls/toxicity , Social Behavior
3.
Rev Med Liege ; 69 Spec No: 25-30, 2014.
Article in French | MEDLINE | ID: mdl-25796794

ABSTRACT

Epidemiological and experimental data highlight the fetal and early postnatal life as critical periods for the effects of endocrine disrupting chemicals (EDCs), since exposure to EDCs during these periods can predispose to disease later in life. EDCs' effects include disorders of the reproductive system throughout life (abnormalities of sexual differentiation, infertility or subfertility and some neoplasia) and disorders of energy balance (obesity and metabolic syndrome). They could also influence the development of the cerebral cortex. However, the demonstration of the involvement of a single EDC remains difficult in human since we are virtually exposed to a mixture of several ubiquitous EDCs which are variably persistent in the environment and the body and have lifelong consequences. Moreover, since their dose-response relationship can be non-monotonic, setting a threshold dose for EDCs effects has become meaningless. Pregnant women, newborns and young children appear to be mostly at risk. However, the role of the physician remains difficult and raises several questions: how can we formulate justified, applicable and updated recommendations that are not counterproductive or alarmist...in a society that has to take the necessary steps to regulate production and protect the population?


Subject(s)
Biomedical Research , Endocrine Disruptors , Public Health , Humans
4.
J Neuroendocrinol ; 25(11): 1079-87, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24028442

ABSTRACT

The timing of puberty has been mainly studied in females for several reasons, including the possible evaluation of a precise timer (i.e. menarcheal age) and concerns with respect to the high prevalence of precocity in females as opposed to males. Human evidence of altered female pubertal timing after exposure to endocrine disrupting chemicals (EDCs) is equivocal. Among the limiting factors, most studies evaluate exposure to single EDCs at the time of puberty and hardly assess the impact of lifelong exposure to mixtures of EDCs. Some rodent and ovine studies indicate a possible role of foetal and neonatal exposure to EDCs, in accordance with the concept of an early origin of health and disease. Such effects possibly involve neuroendocrine mechanisms because the hypothalamus is a site where homeostasis of reproduction, as well as control of energy balance, is programmed and regulated. In our previous studies, pulsatile gonadotrophin-releasing hormone (GnRH) secretion control via oestrogen, glutamate and aryl hydrocarbon receptors was shown to be involved in the mechanism of sexual precocity after early postnatal exposure to the insecticide dichlorodiphenyltrichloroethane. Very recently, we have shown that neonatal exposure to the potent synthetic oestrogen diethylstilbestrol (DES) is followed by early or delayed puberty depending on the dose, with consistent changes in developmental increase of GnRH pulse frequency. Moreover, DES results in reduced leptin stimulation of GnRH secretion in vitro, an effect that is additive with prenatal food restriction. Thus, using puberty as an endpoint of the effects of EDC, it appears necessary to consider pre- and perinatal exposure to low doses and to pay attention to the other conditions of prenatal life, such as energy availability, keeping in mind the possibility that puberty could not only be advanced, but also delayed through neuroendocrine mechanisms.


Subject(s)
Endocrine Disruptors/adverse effects , Gonadotropin-Releasing Hormone/metabolism , Hippocampus/drug effects , Hypothalamus/drug effects , Sexual Development/drug effects , Animals , Female , Humans
5.
Endocr Dev ; 22: 271-86, 2012.
Article in English | MEDLINE | ID: mdl-22846535

ABSTRACT

Eating disorders (EDs) are conditions which are becoming more and more widespread among adolescents and they often lead them to seek the opinion of a professional health caregiver, including gynecologists and pediatricians. EDs, and particularly anorexia nervosa (AN), are usually classified as psychological or psychiatric disorders, but they may have major somatic implications and complications as osteoporosis, nutritional deficiencies, cerebral atrophy, cardiac and metabolic disorders. A key issue in the management is prevention or reduction of both the serious somatic consequences and the important mental health consequences (e.g. depression, psychosocial withdrawal, phobia and suicide), integrating different perspectives (psychological or psychiatric - individual and familial -, genetic, nutritional, pediatric, gynecological). Adolescence is a critical period for the onset of EDs though they may also involve younger children. In this case, the consequences on the development (height, weight, puberty) can also be significant. In this review, we will focus on eating disorders in adolescent girls with an emphasis on AN. We describe variations in ED characteristics and their management depending on age at occurrence. A possible ED should be considered by pediatricians consulted about delayed female growth and puberty as well as gynecologists in patients with primary or secondary amenorrhea or infertility.


Subject(s)
Adolescent Nutritional Physiological Phenomena , Feeding and Eating Disorders/diagnosis , Feeding and Eating Disorders/therapy , Adolescent , Adolescent Nutritional Physiological Phenomena/physiology , Age of Onset , Feeding and Eating Disorders/epidemiology , Female , Growth Charts , Humans , Models, Biological , Pediatrics/methods
6.
Rev Med Liege ; 66(11): 581-8, 2011 Nov.
Article in French | MEDLINE | ID: mdl-22216731

ABSTRACT

The gynaecological issues encountered in children and teenagers lay at the intersection of paediatric endocrinology and gynaecology. More than ten years ago, an outpatient clinic in paediatric endocrinology and gynaecology has been created. Here, we review the last 6 years. 214 girls were included, considering only the first visit for each patient. Collected data are initial concern for this consultation, age at first consultation and confirmed or suspected diagnosis. A classification is done according to the initial concern of patients in six categories. Principal queries concern pubertal development, precocious pilosity or abnormalities in menstrual cycles. Vulvovaginitis and morphologic abnormalities are also frequently encountered. This consultation suggests a paediatric approach with a child feeling confident and a gynaecological examination with a specialist knowing the anatomy particularities and the development of the children. This article focuses on the importance of specific gynaecological examination in children and reviews the main diseases encountered.


Subject(s)
Endocrinology , Gynecological Examination , Gynecology , Pediatrics , Referral and Consultation , Adolescent , Adolescent Health Services/organization & administration , Ambulatory Care Facilities/organization & administration , Belgium/epidemiology , Child , Child Health Services/organization & administration , Child, Preschool , Endocrine System Diseases/diagnosis , Female , Genital Diseases, Female/diagnosis , Genital Diseases, Female/epidemiology , Gynecological Examination/methods , Gynecological Examination/standards , Gynecological Examination/statistics & numerical data , Humans , Infant , Menstruation Disturbances/diagnosis , Menstruation Disturbances/epidemiology , Physical Examination/statistics & numerical data , Retrospective Studies , Vaginal Diseases/diagnosis , Vaginal Diseases/epidemiology , Vulvar Diseases/diagnosis , Vulvar Diseases/epidemiology , Young Adult
7.
Rev Med Liege ; 65(11): 634-41, 2010 Nov.
Article in French | MEDLINE | ID: mdl-21189530

ABSTRACT

Congenital Isolated hypogonadotropic hypogonadism (CIHH) is caused by an inherited mechanism of impairment of the pituitary-gonadal axis, interfering with gonads' control. Currently, different forms of HHCI with (Kallmann syndrome or KS) or without anosmia-hyposmia are known. There are six forms of KS already described but in several cases no genetic mutation is found. The genetic anomalies already described are: KAL1 (locus Xp23) coding for anosmine-1, KAL-2 or FGFRI (8p11. locus 2 - p11.1) coding for Fibroblast Growth Factor Receptor 1 (FGFR1), KAL4 or PROk2 (locus 3p21.1) and KAL3 or ProKR2 (locus 20p13) coding respectively for the Prokinecitin-2 and its receptor, KAL5 or CHD7 (locus_8q12.1) coding for a chromodomain helicase DNA-binding protein-7 gene (CHD7) and lastly KAL6 or FGF8 (10Q 24 loci) coding for Fibroblast Growth Factor 8. The other genetic anomalies without anosmia are less frequent. These are associated either with Gnrhl gene (8p2-11. 2), GnRHR (4q21.2), GPR54 (19p13),TAC3R or neurokinine receptor 3 (4 q 25), LH (19q13.32) or FSH (11p13). The isolated congenital hypogonadotrophic hypogonadism phenotype is variable depending on gender, the importance of the deficit, and ultimately, according to a specific regulatory mechanism of the axis, affected by an inherited genetic anomaly. In this review, we describe the essential aspects of the different phenotypes and genotypes of HHCI, in order to assess clinicians an early disease's diagnosis and management.


Subject(s)
Hypogonadism/congenital , Hypogonadism/genetics , Diagnosis, Differential , Genetic Counseling , Humans , Hypogonadism/diagnosis , Hypogonadism/therapy
8.
Rev Med Liege ; 65(5-6): 250-5, 2010.
Article in French | MEDLINE | ID: mdl-20684402

ABSTRACT

Therapeutic education (TPE) aims to enable the patient suffering from a chronic diseases to manage his/ her illness and treatment, and prevent avoidable complications, while keeping or improving his/her quality of life. It comprises a set de practical tools aiming the patient to acquire skills to manage himself/herself the disease, its care and supervision, in partnership with healthcare providers. TPE may contribute to improve therapeutic compliance and to reduce clinical inertia, two drawbacks frequently encountered in the management of patients with chronic diseases. As an illustration, we briefly present EDUDORA ("Education thérapeutique et préventive face au diabète et a l'obésité a risque chez l'adulte et l'adolescent" = "Preventive and therapeutic education for diabetes and at risk obesity in adults and adolescents"), an ongoing original project in three frontier regions (Wallonia - Grand-Duchy of Luxembourg - Lorraine).


Subject(s)
Attitude of Health Personnel , Patient Compliance , Guideline Adherence , Health Personnel/education , Humans , Patient Education as Topic
9.
J Neuroendocrinol ; 19(3): 181-8, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17280591

ABSTRACT

The present study aimed to investigate the effects of leptin and ghrelin on pulsatile pulsatile gonadotrophin-releasing hormone (GnRH) secretion in vitro with emphasis on neuropeptide mediators and changes between prepuberty (15 days) and sexual maturity (50 days) in the male rat. When hypothalamic explants were studied 90 min after an intraperitoneal injection of leptin, ghrelin or agouti-related protein (AgRP) at 15 days, the GnRH interpulse interval (IPI) was significantly increased by ghrelin and AgRP and decreased by leptin. At 50 days, an increase in GnRH IPI was also caused by ghrelin and AgRP. When the peptides were directly incubated with the explants, the effects of leptin and AgRP in vitro were consistent with those seen after in vivo administration. By contrast, ghrelin resulted in a reduction of GnRH IPI and this was observed at 15 days only. To delineate the neuropeptide mediators of leptin and the effects of ghrelin in the hypothalamus, various hypothalamic neuropeptides and antagonists were used in vitro. At 15 days, the GnRH IPI was significantly decreased after incubation with cocaine and amphetamine-regulated transcript (CART), alpha-melanocyte-stimulating hormone, corticotrophin-releasing factor (CRF) and neuropeptide Y (NPY). The reduction of GnRH IPI caused by leptin was partially prevented by either an anti-CART antiserum or SHU 9119, a melanocortin MC3/MC4 receptor antagonist or a CRF receptor antagonist. The NPY-Y5 receptor antagonist did not influence the effects of leptin whereas that antagonist totally prevented the decrease in GnRH IPI caused by ghrelin. The ghrelin-induced reduction of GnRH IPI was partially prevented by SHU 9119. When used alone, SHU 9119 or a CRF-receptor antagonist resulted in increased GnRH IPI at 50 days while they had no effects at 15 days. The NPY-Y5 receptor antagonist resulted in increased GnRH IPI at 15 and 50 days. In conclusion, leptin and ghrelin show opposing effects on pulsatile GnRH secretion after administration in vivo whereas they both have stimulatory effects in vitro. Such effects involve consistently the anorectic peptides CART and CRF for leptin that are mainly active at 15 days. The melanocortigenic system appears to mediate the effects of both leptin and ghrelin. The effects of ghrelin also involve NPY receptors and operate effectively before and at sexual maturity.


Subject(s)
Gonadotropin-Releasing Hormone/metabolism , Hypothalamus/metabolism , Leptin/physiology , Peptide Hormones/physiology , Sexual Maturation/physiology , Agouti-Related Protein , Analysis of Variance , Animals , Corticotropin-Releasing Hormone/metabolism , Female , Ghrelin , In Vitro Techniques , Intercellular Signaling Peptides and Proteins/physiology , Male , Nerve Tissue Proteins/metabolism , Periodicity , Rats , Rats, Wistar , Receptors, Melanocortin/physiology , Signal Transduction/physiology , Statistics, Nonparametric
10.
Rev Med Liege ; 61(7-8): 593-9, 2006.
Article in French | MEDLINE | ID: mdl-17020234

ABSTRACT

Prader Willi syndrome can be viewed as a physiopathological model of obesity. Such patients deserve specific management, preferably in a multidisciplinary setting. The paper reports on 6 patients followed in the paediatric endocrine service at the University of Liege.


Subject(s)
Patient Care Team , Prader-Willi Syndrome/therapy , Child , Humans , Prader-Willi Syndrome/diagnosis , Prader-Willi Syndrome/genetics
12.
Mol Cell Endocrinol ; 254-255: 187-201, 2006 Jul 25.
Article in English | MEDLINE | ID: mdl-16720078

ABSTRACT

Natural hormones and some synthetic chemicals spread into our surrounding environment share the capacity to interact with hormone action and metabolism. Exposure to such compounds can cause a variety of developmental and reproductive detrimental abnormalities in wildlife species and, potentially, in human. Many experimental and epidemiological data have reported that exposure of the developing fetus or neonate to environmentally relevant concentrations of some among these endocrine disrupters induces morphological, biochemical and/or physiological disorders in brain and reproductive organs, by interfering with the hormone actions. The impact of such exposures on the hypothalamic-pituitary-gonadal axis and subsequent sexual maturation is the subject of the present review. We will highlight epidemiological human studies and the effects of early exposure during gestational, perinatal or postnatal life in female rodents.


Subject(s)
Endocrine Disruptors/adverse effects , Estrogens/adverse effects , Puberty/drug effects , Reproduction/drug effects , Sexual Maturation/drug effects , Animals , Central Nervous System/drug effects , Female , Humans , Models, Biological , Peripheral Nervous System/drug effects , Rodentia
13.
Rev Med Liege ; 60(5-6): 313-9, 2005.
Article in French | MEDLINE | ID: mdl-16041859

ABSTRACT

The management and follow up of diabetes in youth is a multidisciplinary challenge due to both short and long term objectives. Awareness of the feelings and problems faced by the families is critical. The experience of our team has started in the 1960s and is briefly described and updated in this article.


Subject(s)
Child Welfare , Diabetes Mellitus/therapy , Patient Education as Topic , Child , Child, Preschool , Diabetes Mellitus/diagnosis , Diagnosis, Differential , Humans , Nutritional Status , Patient Care Team , Pediatrics , Social Support
14.
Rev Med Liege ; 60(5-6): 320-1, 2005.
Article in French | MEDLINE | ID: mdl-16035287

ABSTRACT

The management of adolescents with diabetes mellitus involves specific aspects at diagnosis and during follow-up. A type 2 diabetes should be excluded at diagnosis since this condition is increasingly observed in closed relationhip with the progression of obesity in young people. During initial education process, the parents should be involved while a specific space and time for interaction with the adolescents is required. During follow-up, all aspects of the adolescent process should be taken into account together with diabetes. This includes risk-taking or exploratory behaviours, feeling of being different, angryness and difficulties for the adolescents to consider the long-term complication risk. Special attention should be devoted to the transition towards adult care.


Subject(s)
Adolescent Behavior , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/therapy , Risk-Taking , Adolescent , Adolescent Health Services , Anger , Humans , Obesity/etiology , Obesity/prevention & control , Self Concept
15.
Arch Dis Child ; 90(12): 1223-6, 2005 Dec.
Article in English | MEDLINE | ID: mdl-15941770

ABSTRACT

BACKGROUND: Children with type 1 diabetes should be encouraged to participate in physical activity because exercise can benefit insulin sensitivity and improve known risk factors for atherosclerosis. METHODS: Physical activity patterns of 127 children and adolescents with stable type 1 diabetes were investigated by 24 hour continuous heart rate monitoring. The percentage of heart rate reserve was used to measure the amounts of physical activity at different intensities. The results were compared with normative data. RESULTS: Diabetic preschoolchildren accumulated 192.7 (78.1), 39.1 (24.3), and 21.3 (9.4) minutes/day (mean (SD)) of light, moderate, and vigorous physical activity, respectively. At the same activity levels, diabetic schoolchildren accumulated 168.9 (76.7), 37.9 (15.9), and 19.0 (14.8) minutes/day, and diabetic teenagers accumulated 166.3 (67.5), 45.6 (26.9), and 25.2 (15.3) minutes/day. Diabetic schoolchildren were significantly more active than healthy peers when considering moderate activity; diabetic teenagers were significantly more active when considering moderate and vigorous activity. There was a negative correlation between the most recent glycated haemoglobin and the time spent in light activities in schoolchildren, and a negative correlation between mean glycated haemoglobin for one year and time spent in light and moderate activities in schoolchildren. CONCLUSION: The majority of our diabetic patients meet the classical paediatric guidelines for physical activity and compare favourably with their healthy peers.


Subject(s)
Diabetes Mellitus, Type 1/rehabilitation , Motor Activity/physiology , Adolescent , Age Factors , Child , Child, Preschool , Diabetes Mellitus, Type 1/blood , Diabetes Mellitus, Type 1/physiopathology , Diabetes Mellitus, Type 1/psychology , Electrocardiography, Ambulatory , Exercise , Female , Glycated Hemoglobin/metabolism , Health Behavior , Heart Rate , Humans , Male , Time Factors
16.
Arch Dis Child ; 90(3): 267-8, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15723912

ABSTRACT

The age at diagnosis of 242 girls with Turner syndrome (TS) treated in Belgium with growth hormone between 1991 and 2002 was evaluated. The median (range) age at diagnosis was 6.6 (0-18.3) years. Patients with 45,X karyotype were diagnosed earlier than patients with other karyotypes. Compared to a previous survey, performed on 100 patients 12 years earlier, more patients were diagnosed during infancy and childhood, and less during adolescence. However, in 22% of the girls the diagnosis was made after the age of 12 years; these girls showed the largest height deficit. As early diagnosis has several potential advantages we recommend that a cytogenetic analysis should be considered in all girls with unexplained short stature with height below -2 SD of the mean for age or below the parent specific lower limit of height.


Subject(s)
Turner Syndrome/diagnosis , Adolescent , Age Factors , Age of Onset , Body Height , Child , Child, Preschool , Early Diagnosis , Female , Follow-Up Studies , Growth Hormone/therapeutic use , Humans , Infant , Infant, Newborn , Karyotyping/methods , Turner Syndrome/drug therapy , Turner Syndrome/genetics
17.
Endocrinology ; 146(5): 2313-23, 2005 May.
Article in English | MEDLINE | ID: mdl-15661860

ABSTRACT

Although the interactions between sex steroids and GnRH have been extensively studied, little is known about the mechanism of estradiol (E2) effects on GnRH secretion. In the present study, we used retrochiasmatic hypothalamic explants of 50-d-old male rats, and we observed that E2 significantly increased the glutamate-evoked GnRH secretion in vitro within 15 min in a dose-dependent manner. E2 also significantly increased the L-arginine-evoked GnRH secretion. E2 effects were time dependent because the initially ineffective 10(-9) M concentration became effective after 5 h of incubation. The E2 effects involved the estrogen receptor (ER) alpha because they were similarly obtained with the specific ER alpha agonist 1,3,5-tris(4-hydroxyphenyl)-4-propyl-1H-pyrazole. The use of glutamate receptor agonists and antagonists indicated that E2 effects on GnRH secretion evoked by both glutamate and L-arginine involved the 2-amino-3-hydroxy-5-methyl-4-isoxazol propionic acid/kainate receptors. Similar E2 effects on the kainate-evoked secretion were observed throughout development in both sexes. The observation of similar E2 effects using explants containing the median eminence alone indicated that the median eminence was a direct target for E2 rapid effects on the glutamate-evoked GnRH secretion. The signaling pathways involved in E2 effects included an increase in intracellular calcium and the activation of protein kinase A, protein kinase C, and MAPK. It is concluded that E2 can stimulate the glutamate- and nitric oxide-evoked GnRH secretion in vitro through a rapid pathway involving the ER and kainate receptor as well as through a slower mechanism responding to lower E2 concentrations.


Subject(s)
Estradiol/pharmacology , Gonadotropin-Releasing Hormone/metabolism , Hypothalamus/metabolism , Receptors, Estrogen/physiology , Receptors, Kainic Acid/physiology , Signal Transduction/physiology , Aging , Animals , Arginine/pharmacology , Estrogen Receptor alpha/agonists , Estrogen Receptor alpha/physiology , Female , Glutamic Acid/pharmacology , Hypothalamus/drug effects , Kinetics , Male , Median Eminence/drug effects , Median Eminence/metabolism , Nitric Oxide/pharmacology , Preoptic Area/drug effects , Preoptic Area/metabolism , Rats , Rats, Wistar , Receptors, Glutamate/drug effects , Receptors, Glutamate/physiology , Receptors, Kainic Acid/drug effects
18.
Horm Res ; 62(4): 161-7, 2004.
Article in English | MEDLINE | ID: mdl-15297800

ABSTRACT

BACKGROUND: Most girls with Turner syndrome (TS) are intensively followed by paediatricians, but are lost to follow-up when they reach adulthood. To gain insight into the adult medical and psychosocial situation, we performed a survey in young adult TS patients. PATIENTS AND METHODS: A questionnaire concerning current health status, education, occupation and living situation was sent to 160 young adult TS women, all treated during childhood with GH and oestrogen if needed. RESULTS: We received 102 completed questionnaires. Mean +/- SD age at reception of the questionnaire was 23.4 +/- 3.3 years, height 153.3 +/- 5.2 cm, body mass index 23.7 +/- 4.9 kg/m(2). Age and auxological parameters were comparable between responders and non-responders. Thirteen (12.7%) responders were not under regular medical care; 15 (14.7%) were seen by a general practitioner, while 28 (27.4%) needed several specialists. Forty-one (40.2%) patients reported health problems. The most frequently reported problem was hypertension (10.7%), followed by hypothyroidism (5.8%) and back problems (4.9%). Twenty-four (23.5%) of the 41 patients were taking medication for the indicated health problems. Twenty-six (25.5%) women had undergone spontaneous puberty; 16 of them reported spontaneous menstruations while 10 received oestrogen replacement therapy. Of the 76 women with induced puberty, 11 (14.5%) were not taking any oestrogen anymore. Compared with the general population, more TS women attended university and more obtained higher education. Forty-six women (45.1%) were working full-time, 7 (6.9%) were unemployed, and 4 (3.9%) received an allocation. Seventy (68.6%) patients were still living with their parents, while 18 (17.6%) were living together or married, and 14 (13.7%) were living alone. CONCLUSIONS: The transition of adolescents with TS to adult medical care is not optimal in Belgium. Although 40.2% of these young women reported health problems, 12.7% did not consult any physician. Many TS women did not take oestrogen replacement therapy. A specialized multidisciplinary approach for adults with TS is needed in order to optimize health and psychosocial status in these women.


Subject(s)
Aging , Health Status , Mental Health , Social Class , Turner Syndrome/physiopathology , Turner Syndrome/psychology , Adolescent , Adult , Aging/psychology , Delivery of Health Care , Education , Employment , Female , Humans , Residence Characteristics , Surveys and Questionnaires
19.
Eur J Endocrinol ; 151(1): 67-72, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15248824

ABSTRACT

OBJECTIVE: Since the availability of recombinant human growth hormone (rhGH) all children with growth hormone deficiency (GHD) living in Belgium are offered rhGH treatment after approval by a peer-review board. In this study, we evaluated the prevalence and demographic features of childhood GHD in Belgium during the period 1986-2001 and we compared them with the data from other countries. METHODS: Diagnostic, demographic and baseline auxological data of 714 children diagnosed as having GHD between 1986 and 2001 were retrieved from the database of the Belgian Study Group for Paediatric Endocrinology. RESULTS: The prevalence of GHD in Belgium was estimated to be 1/5600. The origin of GHD was idiopathic (idGHD) in 41% of the patients, congenital (congGHD) in 20% and acquired (acqGHD) in 35%. During the first 4 years (1986-1989) more patients were classified as idGHD; thereafter the distribution between the three aetiology groups did not change. In all groups, boys outnumbered girls but this preponderance was especially pronounced in congGHD patients (male:female=4:1) with a central malformation that associates an anterior pituitary hypoplasia, a missing, fine or normal pituitary stalk and an ectopic posterior pituitary. Thirteen percent of the patients with idGHD, 50% with congGHD and 52% with acqGHD had multiple pituitary deficiencies. Patients with congGHD were the youngest (mean+/-s.d. age: 6.5+/-4.7 years) and were the shortest (-3.0+/-1.3 standard deviation score (SDS)) at the start of rhGH treatment. There was no time trend over the studied period for age and height at onset of GH therapy. CONCLUSION: In Belgium, the prevalence of childhood GHD can be estimated as 1/5600 which is comparable to other recent surveys. The yearly number of new patients for the different aetiologies and the auxological parameters have remained relatively constant over the last 16 years.


Subject(s)
Growth Disorders/epidemiology , Human Growth Hormone/deficiency , Adolescent , Age Distribution , Belgium/epidemiology , Birth Weight , Body Height , Child , Child, Preschool , Female , Growth Disorders/drug therapy , Growth Disorders/etiology , Human Growth Hormone/therapeutic use , Humans , Infant , Infant, Newborn , Male , Parents , Pituitary Diseases/complications , Pituitary Diseases/drug therapy , Pituitary Diseases/epidemiology , Prevalence , Severity of Illness Index , Sex Distribution
20.
Endocrinology ; 145(6): 2775-83, 2004 Jun.
Article in English | MEDLINE | ID: mdl-14988382

ABSTRACT

Our aim was to study the effect of estradiol (E2) on pulsatile GnRH secretion in vitro in relation to sex and development. When hypothalamic explants obtained from 5- and 15-d-old female rats were exposed to E2 (10(-7) m), a reduction of GnRH interpulse interval (IPI) occurred but not at 25 and 50 d of age. This effect was prevented by the estrogen receptor antagonist ICI 182.780 and the AMPA/kainate receptor antagonist DNQX but not by the AMPA and N-methyl-d-aspartate receptor antagonists SYM 2206 and MK-801. E2 did not affect GnRH IPI in hypothalamic explants obtained from male rats. Therefore, the possible relation between the female-specific effects of E2 in vitro and perinatal sexual differentiation was investigated. When using explants obtained from female rats masculinized through testosterone injection on postnatal d 1, E2 was no longer effective in vitro at 5 and 15 d. In addition, with explants obtained from male rats demasculinized through perinatal aromatase inhibitor treatment, E2 became capable of decreasing GnRH IPI in vitro at 15 d. To study the possible pathophysiological significance of early hypothalamic E2 effects, female rats received a single E2 injection on postnatal d 10. This resulted in reduced GnRH IPI in vitro on d 15 as well as advancement in age at vaginal opening and first estrus. In conclusion, E2 decreases the GnRH IPI in the immature female hypothalamus in vitro through a mechanism that depends on perinatal brain sexual differentiation and that could be involved in some forms of female precocious puberty.


Subject(s)
Estradiol/analogs & derivatives , Estradiol/pharmacology , Gonadotropin-Releasing Hormone/metabolism , Hypothalamus/drug effects , Hypothalamus/metabolism , Aging , Animals , Animals, Newborn , Aromatase Inhibitors , Dizocilpine Maleate/pharmacology , Drug Administration Schedule , Estrogen Antagonists/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , Female , Fulvestrant , Humans , In Vitro Techniques , Male , Phthalazines/pharmacology , Puberty, Precocious/chemically induced , Quinoxalines/pharmacology , Rats , Rats, Wistar , Sex Characteristics , Sex Differentiation/drug effects , Testosterone/administration & dosage , Virilism/chemically induced
SELECTION OF CITATIONS
SEARCH DETAIL
...